Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials.

MLA

Strilciuc, Stefan, et al. “Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials.” Pharmaceuticals (14248247), vol. 14, no. 12, Dec. 2021, p. 1297. EBSCOhost, https://doi.org/10.3390/ph14121297.

APA

Strilciuc, S., Vécsei, L., Boering, D., Pražnikar, A., Kaut, O., Riederer, P., & Battistin, L. (2021). Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials. Pharmaceuticals (14248247), 14(12), 1297. https://doi.org/10.3390/ph14121297

Chicago

Strilciuc, Stefan, László Vécsei, Dana Boering, Aleš Pražnikar, Oliver Kaut, Peter Riederer, and Leontino Battistin. 2021. “Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials.” Pharmaceuticals (14248247) 14 (12): 1297. doi:10.3390/ph14121297.